Skip to main content

Iradimed Corp

IRMD
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001325618

In the last 90 days, Iradimed Corp insiders filed 0 open-market purchases and 1 sale; 213 institutions reported holding it in 13F filings for Q2 2026, worth $750.2M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Iradimed Corp changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of IRMD: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders5562+7
Shares4.73M4.77M+44.8K (+0.9%)
Value$122.2M$140.5M+$18.3M (+15.0%)

New holders (11)

Institutions that held Iradimed Corp at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to IRMD in Q2 2021
InstitutionSharesValue% of portfolio
Formidable Asset Management, LLC10,000$337.0K0.07%
LPL Financial LLC7,300$215.0K0.00%
Goldman Sachs Group Inc7,145$210.0K0.00%
Panagora Asset Management Inc5,781$170.0K0.00%
JFS Wealth Advisors, LLC1,750$51.0K0.01%
Acadian Asset Management LLC1,305$38.0K0.00%
Lazard Asset Management LLC824$24.0K0.00%
State of Wyoming575$17.0K0.01%
Globeflex Capital L P513$15.0K0.00%
Proequities, Inc.128$4.00K0.00%
Berman Capital Advisors, LLC41$1.00K0.00%

Sold out (4)

Institutions that held Iradimed Corp at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of IRMD in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
California Public Employees Retirement System11,700$302.0K
Denali Advisors LLC800$21.0K
Bank of Montreal179$4.00K
Quadrant Capital Group LLC12$0